Latest News & Updates
Breaking News
8 hours ago
Vaibhavi M.
Other trending news you may like to read
Praxis Advances Essential Tremor Program After Successful FDA Pre-NDA Meeting And Expects Early 2026 Submission
Praxis secures FDA alignment in its pre-NDA meeting and prepares a 2026 NDA submission for ulixacaltamide, a potential new therapy for essential tremor.
Vaibhavi M.
Merck’s New Animal Health’s Isoxazoline Parasiticide EXZOLT CATTLE-CA1 For Screwworm And Tick Control Set For U.S. Launch Following FDA Conditional Clearance
FDA grants conditional approval to Merck’s EXZOLT CATTLE-CA1, a new fluralaner treatment for screwworm and cattle fever ticks in beef cattle.
Vaibhavi M.
Praxis Reports Early-Stop Success In EMBOLD Trial, Advancing Relutrigine For SCN2A And SCN8A Epileptic Encephalopathies
Praxis reports strong EMBOLD results for relutrigine in SCN2A/SCN8A DEEs, prompting early study stop and FDA review toward a potential NDA.
Vaibhavi M.
Takeda Completes Oncology Collaboration With Innovent, Secures Global Rights To Late-Stage Cancer Assets
Takeda closes its oncology partnership with Innovent, securing global rights to late-stage cancer therapies IBI363 and IBI343 to expand its pipeline.
Vaibhavi M.
